Pharma group Krka ups net profit 39% last year to EUR 242m
Novo Mesto, 30 January - The group around the Novo Mesto-based drug maker Krka generated EUR 1.49 billion in sales revenue in 2019, or 12% more than in the year before, while net profit was up 39% to EUR 242 million, according to an estimate released by the management board on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 2.077 characters (without spaces) or 437 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.